NCT00633217 - Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) | Biotech Hunter

Enrollment

247

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Fluticasone Propionate/Salmeterol DISKUS 250/50mcg

treatment drug

DRUG

Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg

treatment drug

Trial Locations (16)

16508

GSK Investigational Site, Erie

23229

GSK Investigational Site, Richmond

26505

GSK Investigational Site, Morgantown

27909

GSK Investigational Site, Elizabeth City

29303

GSK Investigational Site, Spartanburg

29309

GSK Investigational Site, Union

29340

GSK Investigational Site, Gaffney

29615

GSK Investigational Site, Greenville

35501

GSK Investigational Site, Jasper

36608

GSK Investigational Site, Mobile

63301

GSK Investigational Site, Saint Charles

70115

GSK Investigational Site, New Orleans

70503

GSK Investigational Site, Lafayette

70584

GSK Investigational Site, Sunset

75110

GSK Investigational Site, Corsicana

29406-7108

GSK Investigational Site, Charleston